KC Huang Scholars

Jian Cai

  • M.Sci., Pharmaceutical Chemistry, Shanghai Institute of Pharmaceutical Industry
  • Ph.D., Pharmacology and Toxicology, University of Louisville
    • Dissertation (1999): N-(carboxymethyl)valine adduct in hemoglobin:  A biomarker of advanced glycation end product formation and oxidative stress

Wei (Wendy) Yuan Chang

  • B.S., Pharmacy, Tapei Medical University
  • M.S., Pharmacology and Toxicology, University of Louisville
    • Thesis (2004): Mechanism of oxidative stress induced cell toxicity
  • Ph.D., Pharmacology and Toxicology, University of Louisville
    • Dissertation (2006): Mechanism of 4-hydroxynoneal induced toxicity in Jurkat CD4+ T lymphocytes

Pei-Hsin (Penny) Cheng

  • B.S., Biological Sciences, National Sun Yat-Sen University
  • M.S., Biological Sciences, National Sun Yat-Sen University
  • M.S., Pharmacology and Toxicology, University of Louisville
    • Thesis (2011): Adenovirus-induced cyclin E activated CDK2 for virus replication
  • Ph.D., Pharmacology and Toxicology, University of Louisville
    • Dissertation (2013): Cyclin E induction and oncolytic replication of E1B-deleted adenoviruses

Tuo Shao

  • B.S., Pharmacy, Wuhan Bioengineering Institute
  • M.S., Neuropharmacology, Wenzhou Medical University
  • Ph.D., Pharmacology & Toxicology, University of Louisville
    • Dissertation (2017):  The role of HIF-1α in intestinal epithelial barrier function in alcoholic liver disease

Hongxue Shi

  • Bachelor of Pharmaceutical Engineering, Huaiyin Institute of Technology
  • M.S., Chinese Pharmacology, Wenzhou Medical University
  • Ph.D., Pharmacology & Toxicology, University of Louisville
    • Dissertation (2018): The effects of polychlorinated biphenyls exposure on non-alcoholic fatty liver disease: Role of aryl hydrocarbon receptor

Qian (Zoe) Lin

  • B.S. Pharmacy, Wenzhou Medical University
  • M.S., Pharmaceutical Science, Wenzhou Medical University
  • Ph.D. Pharmacology & Toxicology, University of Louisville
    • Dissertation (2018):  A novel fibroblast growth factor 1 variant reverses nonalcoholic fatty liver disease in type 2 diabetes

Al Hassan Kyakulaga

  • Bachelor of Biomedical Laboratory Technology, Makerere University
  • M.S., Pharmacology, Markerere University
  • M.S., Pharmacology & Toxicology, University of Louisville
  • Ph.D., Pharmacology & Toxicology, University of Louisville
    • Dissertation (2019):  Therapeutic potential of Withaferin A against non-small cell lung cancer

Mohamed Elnagdy

  • M.B. Ch.B., Cairo University